Lexicon Pharmaceuticals

LXRX

LXRX
Lexicon Pharmaceuticals Stock Quote
$1.36 -$0.05 -3.5%
BATS BZX Real Time Price as of August 22, 2019, 4:00 p.m. EDT View Interactive LXRX Charts

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.

News & Analysis: Lexicon Pharmaceuticals

The Fool has written over 100 articles on Lexicon Pharmaceuticals.

All

Market Moves

Earnings




What's Next for Lexicon Pharmaceuticals?

American regulators rejected a type 1 diabetes treatment that analysts predicted would eventually eclipse $450 million in annual revenue.








Interactive Chart